CSIMarket Company Name, Ticker, Industry, else..
 
Vaso Corporation  (VASO)
Other Ticker:  
 
 
Price: $0.1300 $0.00 0.000%
Day's High: $0.13 Week Perf: -3.49 %
Day's Low: $ 0.13 30 Day Perf: -3.42 %
Volume (M): 0 52 Wk High: $ 0.30
Volume (M$): $ 0 52 Wk Avg: $0.18
Open: $0.13 52 Wk Low: $0.11



 Market Capitalization (Millions $) 12
 Shares Outstanding (Millions) 95
 Employees 31
 Revenues (TTM) (Millions $) 87
 Net Income (TTM) (Millions $) 1
 Cash Flow (TTM) (Millions $) 15
 Capital Exp. (TTM) (Millions $) 1

Vaso Corporation
Vaso Corporation is a publicly-traded medical technology company that is focused on providing solutions and services to the healthcare industry. The company specializes in developing and marketing diagnostic imaging and healthcare IT products and services, as well as offering managed services to medical facilities across the United States.

Founded in 1987, Vaso Corporation is headquartered in New York and has operations in over 10 countries, including Canada, the United Kingdom, and Australia. The company has a diverse portfolio of products and services that are designed to improve patient care and optimize clinical workflow.

Diagnostic Imaging Products and Services:
Vaso Corporation offers a range of imaging products and services, including new and refurbished equipment, professional training, and technical support services. The company markets a variety of high-end imaging systems, including Magnetic Resonance Imaging (MRI), Computerized Tomography (CT), and Positron Emission Tomography (PET).

Healthcare IT Products and Services:
The company also provides a suite of IT products and services designed for clinical, financial, and administrative management of healthcare organizations. This includes advanced imaging software, electronic health records, as well as IT support and consulting services.

Managed Services:
Vaso Corporation offers managed services to medical facilities across the United States, including full-service diagnostic imaging management, clinical engineering, and facility management services. With over 500 employees, Vaso Corporation operates as a trusted partner to its clients, delivering comprehensive solutions tailored to meet the unique needs of each facility.

In 2019, Vaso Corporation acquired a majority interest in operating subsidiary VasoHealthcare, solidifying its position as a market leader in the imaging and healthcare technology industry. VasoHealthcare provides a unique combination of new and refurbished equipment, services, and software solutions that integrate seamlessly into new and existing healthcare facilities.

Overall, Vaso Corporation is a dynamic and innovative company that is positioned for growth in response to the ever-changing healthcare landscape. The company's commitment to quality and patient care makes it a highly respected partner, and it continues to forge new partnerships and grow market share as it strives to improve patient outcomes and drive efficiency in healthcare delivery.


   Company Address: 137 Commercial St. Plainview 11803 NY
   Company Phone Number: 997-4600   Stock Exchange / Ticker: VASO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX   -1.52%    
BSX        1.54% 
EW        1.23% 
MDT   -0.36%    
SYK   -1.08%    
ZBH   -4.33%    
• View Complete Report
   



Contract

Vaso Corporation Ends Deal with Achari Ventures, Sets Sights on New Growth Opportunities,

Published Wed, Sep 18 2024 10:31 PM UTC

Vaso Corporation Terminates Business Combination Agreement with Achari Ventures Holdings Corp. I, Eyes Future Growth Plainview, N.Y., Sept. 18, 2024 In a significant pivot, Vaso Corporation (OTCQX: VASO), a leader in medical and IT service industries, announced the termination of its Business Combination Agreement with Achari Ventures Holdings Corp. I (Achari). Vaso has ...
Vaso Corporation

Vaso Corporation Battless Revenue Decline in Challenging Healthcare Market

Vaso Corporation, a leading provider of healthcare solutions and services, recently announced its financial performance for the fiscal third quarter of 2023. Despite a modest reduction in revenue, the company reported unchanged earnings per share (EPS) at $0.01. Revenue decreased by -2.925% to $19.45 million compared to the same period last year.
In contrast to Vaso Corporation's scenario, the remainder of the Medical Equipment & Supplies industry posted a 4.80% growth in revenue during the third quarter of 2023 compared to the same period a year before. This indicates that Vaso Corporation has faced challenges in maintaining its revenue growth while its peers have managed to grow.
The company's EPS remained unchanged from the previous reporting period, and revenue decreased by -4.834% from $20.44 million. Net earnings in the fiscal third quarter of 2023 declined by -52.04%, falling from $2.498 million to $1.198 million compared to the corresponding period a year before. These figures reflect a decrease in profitability for Vaso Corporation.
Vaso Corporation

Vaso Corporation Outshines Competitors with Steady Earnings per Share and Impressive Revenue Growth in Recent Fiscal Period



Vaso Corporation, a prominent player in the Medical Equipment & Supplies industry, recently released its financial results for the most recent fiscal period. The interpretation of these results provides valuable insights that can help gauge the company's performance and anticipate its future prospects.
1. Steady Earnings per Share (EPS) and Revenue Growth:
Vaso Corporation reported a consistent EPS of $0.01 per share, both year-on-year and quarter-to-quarter. While this may appear stagnated, the company managed to surpass its industry contemporaries, which achieved only a 3.97% revenue growth during the same period. Vaso Corporation raised its revenue by 4.794% to $20.44 million compared to the previous year and by 6.326% sequentially.
Vaso Corporation

Vaso Corporation Reports Impressive Revenue Growth and Positive Financial Outlook in the Fiscal Period Ending March 31, 2023

Vaso Corporation, a leader in the Medical Equipment & Supplies industry, has recently announced its fiscal period results ending March 31, 2023. The company broke even at $0.00 per share for the reporting period, compared to $0.00 a year prior, and $0.02 per share from the previous period. This is a significant improvement in the company's performance and a positive indication of its financial health.
The company's revenue has also shown impressive growth, with an increase of 13.005% to $19.22 million from $17.01 million in the comparable period a year ago. However, sequentially, revenue fell by -18.107% from $23.47 million. Despite this decline, the company recorded a net income of $0.454 million, a vast improvement compared to a net shortfall of $-0.344 million the previous year.






Vaso's Segments
Network Services    48.09 % of total Revenue
Software Sales and Support    5.3 % of total Revenue
Commissions    43.91 % of total Revenue
Medical Equipment Sales    2.61 % of total Revenue
Medical Equipment Service    0.15 % of total Revenue
IT Segment    53.39 % of total Revenue
IT Network Services    48.09 % of total Revenue
IT Software Sales and Support    5.3 % of total Revenue
Professional sales service segment    43.91 % of total Revenue
Professional sales service Commissions    43.91 % of total Revenue
Equipment segment    2.76 % of total Revenue
Equipment Medical Equipment Sales    2.61 % of total Revenue
Equipment Medical Equipment Service    0.15 % of total Revenue
Revenue recognized over time    45.5 % of total Revenue
Revenue recognized over time IT Segment    45 % of total Revenue
Revenue recognized over time Equipment segment    0.49 % of total Revenue
Revenue recognized at a point in time    54.57 % of total Revenue
Revenue recognized at a point in time IT Segment    8.39 % of total Revenue
Revenue recognized at a point in time Professional sales service segment    43.91 % of total Revenue
Revenue recognized at a point in time Equipment segment    2.27 % of total Revenue
Equipment    2.76 % of total Revenue
IT    53.39 % of total Revenue
Professional sales service    43.91 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com